<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2) (
 <xref rid="bib3" ref-type="bibr">Colson et al., 2020</xref>; 
 <xref rid="bib11" ref-type="bibr">Gao et al., 2020</xref>). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.
</p>
